Report Detail
Global Insomnia Medication Market Insights and Forecast to 2026
- RnM4165383 |
- 26 August, 2020 |
- Global |
- 146 Pages |
- QYResearch |
- Pharma & Healthcare
Insomnia Medication market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Insomnia Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Insomnia Medication market is segmented into
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants
Segment by Application, the Insomnia Medication market is segmented into
Adults
Kids
Regional and Country-level Analysis
The Insomnia Medication market is analysed and market size information is provided by regions (countries).
The key regions covered in the Insomnia Medication market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Insomnia Medication Market Share Analysis
Insomnia Medication market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Insomnia Medication business, the date to enter into the Insomnia Medication market, Insomnia Medication product introduction, recent developments, etc.
The major vendors covered:
Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals
1 Study Coverage
- 1.1 Insomnia Medication Product Introduction
- 1.2 Market Segments
- 1.3 Key Insomnia Medication Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Insomnia Medication Market Size Growth Rate by Type
- 1.4.2 Nonbenzodiazepine Receptor Agonists
- 1.4.3 Benzodiazepine Receptor Agonists
- 1.4.4 The Selective Melatonin Receptor Agonist Ramelteon
- 1.4.5 Sedating Antidepressants
- 1.5 Market by Application
- 1.5.1 Global Insomnia Medication Market Size Growth Rate by Application
- 1.5.2 Adults
- 1.5.3 Kids
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Insomnia Medication Market Size, Estimates and Forecasts
- 2.1.1 Global Insomnia Medication Revenue 2015-2026
- 2.1.2 Global Insomnia Medication Sales 2015-2026
- 2.2 Global Insomnia Medication, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Insomnia Medication Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Insomnia Medication Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Insomnia Medication Competitor Landscape by Players
- 3.1 Insomnia Medication Sales by Manufacturers
- 3.1.1 Insomnia Medication Sales by Manufacturers (2015-2020)
- 3.1.2 Insomnia Medication Sales Market Share by Manufacturers (2015-2020)
- 3.2 Insomnia Medication Revenue by Manufacturers
- 3.2.1 Insomnia Medication Revenue by Manufacturers (2015-2020)
- 3.2.2 Insomnia Medication Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Insomnia Medication Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Insomnia Medication Revenue in 2019
- 3.2.5 Global Insomnia Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Insomnia Medication Price by Manufacturers
- 3.4 Insomnia Medication Manufacturing Base Distribution, Product Types
- 3.4.1 Insomnia Medication Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Insomnia Medication Product Type
- 3.4.3 Date of International Manufacturers Enter into Insomnia Medication Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Insomnia Medication Market Size by Type (2015-2020)
- 4.1.1 Global Insomnia Medication Sales by Type (2015-2020)
- 4.1.2 Global Insomnia Medication Revenue by Type (2015-2020)
- 4.1.3 Insomnia Medication Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Insomnia Medication Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Insomnia Medication Sales Forecast by Type (2021-2026)
- 4.2.2 Global Insomnia Medication Revenue Forecast by Type (2021-2026)
- 4.2.3 Insomnia Medication Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Insomnia Medication Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Insomnia Medication Market Size by Application (2015-2020)
- 5.1.1 Global Insomnia Medication Sales by Application (2015-2020)
- 5.1.2 Global Insomnia Medication Revenue by Application (2015-2020)
- 5.1.3 Insomnia Medication Price by Application (2015-2020)
- 5.2 Insomnia Medication Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Insomnia Medication Sales Forecast by Application (2021-2026)
- 5.2.2 Global Insomnia Medication Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Insomnia Medication Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Insomnia Medication by Country
- 6.1.1 North America Insomnia Medication Sales by Country
- 6.1.2 North America Insomnia Medication Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Insomnia Medication Market Facts & Figures by Type
- 6.3 North America Insomnia Medication Market Facts & Figures by Application
7 Europe
- 7.1 Europe Insomnia Medication by Country
- 7.1.1 Europe Insomnia Medication Sales by Country
- 7.1.2 Europe Insomnia Medication Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Insomnia Medication Market Facts & Figures by Type
- 7.3 Europe Insomnia Medication Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Insomnia Medication by Region
- 8.1.1 Asia Pacific Insomnia Medication Sales by Region
- 8.1.2 Asia Pacific Insomnia Medication Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Insomnia Medication Market Facts & Figures by Type
- 8.3 Asia Pacific Insomnia Medication Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Insomnia Medication by Country
- 9.1.1 Latin America Insomnia Medication Sales by Country
- 9.1.2 Latin America Insomnia Medication Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Insomnia Medication Market Facts & Figures by Type
- 9.3 Central & South America Insomnia Medication Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Insomnia Medication by Country
- 10.1.1 Middle East and Africa Insomnia Medication Sales by Country
- 10.1.2 Middle East and Africa Insomnia Medication Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Insomnia Medication Market Facts & Figures by Type
- 10.3 Middle East and Africa Insomnia Medication Market Facts & Figures by Application
11 Company Profiles
- 11.1 Eisai
- 11.1.1 Eisai Corporation Information
- 11.1.2 Eisai Description and Business Overview
- 11.1.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Eisai Insomnia Medication Products Offered
- 11.1.5 Eisai Related Developments
- 11.2 Merck
- 11.2.1 Merck Corporation Information
- 11.2.2 Merck Description and Business Overview
- 11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Merck Insomnia Medication Products Offered
- 11.2.5 Merck Related Developments
- 11.3 Pfizer
- 11.3.1 Pfizer Corporation Information
- 11.3.2 Pfizer Description and Business Overview
- 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Pfizer Insomnia Medication Products Offered
- 11.3.5 Pfizer Related Developments
- 11.4 Sanofi
- 11.4.1 Sanofi Corporation Information
- 11.4.2 Sanofi Description and Business Overview
- 11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Sanofi Insomnia Medication Products Offered
- 11.4.5 Sanofi Related Developments
- 11.5 Takeda
- 11.5.1 Takeda Corporation Information
- 11.5.2 Takeda Description and Business Overview
- 11.5.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Takeda Insomnia Medication Products Offered
- 11.5.5 Takeda Related Developments
- 11.6 Vanda Pharmaceuticals
- 11.6.1 Vanda Pharmaceuticals Corporation Information
- 11.6.2 Vanda Pharmaceuticals Description and Business Overview
- 11.6.3 Vanda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Vanda Pharmaceuticals Insomnia Medication Products Offered
- 11.6.5 Vanda Pharmaceuticals Related Developments
- 11.7 Astellas
- 11.7.1 Astellas Corporation Information
- 11.7.2 Astellas Description and Business Overview
- 11.7.3 Astellas Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Astellas Insomnia Medication Products Offered
- 11.7.5 Astellas Related Developments
- 11.8 Dainippon Sumitomo
- 11.8.1 Dainippon Sumitomo Corporation Information
- 11.8.2 Dainippon Sumitomo Description and Business Overview
- 11.8.3 Dainippon Sumitomo Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Dainippon Sumitomo Insomnia Medication Products Offered
- 11.8.5 Dainippon Sumitomo Related Developments
- 11.9 ECR Pharmaceuticals (Valeant)
- 11.9.1 ECR Pharmaceuticals (Valeant) Corporation Information
- 11.9.2 ECR Pharmaceuticals (Valeant) Description and Business Overview
- 11.9.3 ECR Pharmaceuticals (Valeant) Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Products Offered
- 11.9.5 ECR Pharmaceuticals (Valeant) Related Developments
- 11.10 Flynn Pharma
- 11.10.1 Flynn Pharma Corporation Information
- 11.10.2 Flynn Pharma Description and Business Overview
- 11.10.3 Flynn Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Flynn Pharma Insomnia Medication Products Offered
- 11.10.5 Flynn Pharma Related Developments
- 11.1 Eisai
- 11.1.1 Eisai Corporation Information
- 11.1.2 Eisai Description and Business Overview
- 11.1.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Eisai Insomnia Medication Products Offered
- 11.1.5 Eisai Related Developments
- 11.12 Meda
- 11.12.1 Meda Corporation Information
- 11.12.2 Meda Description and Business Overview
- 11.12.3 Meda Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Meda Products Offered
- 11.12.5 Meda Related Developments
- 11.13 Somnus Therapeutics
- 11.13.1 Somnus Therapeutics Corporation Information
- 11.13.2 Somnus Therapeutics Description and Business Overview
- 11.13.3 Somnus Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Somnus Therapeutics Products Offered
- 11.13.5 Somnus Therapeutics Related Developments
- 11.14 Purdue Pharma
- 11.14.1 Purdue Pharma Corporation Information
- 11.14.2 Purdue Pharma Description and Business Overview
- 11.14.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Purdue Pharma Products Offered
- 11.14.5 Purdue Pharma Related Developments
- 11.15 Neurim
- 11.15.1 Neurim Corporation Information
- 11.15.2 Neurim Description and Business Overview
- 11.15.3 Neurim Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Neurim Products Offered
- 11.15.5 Neurim Related Developments
- 11.16 Minerva Neurosciences
- 11.16.1 Minerva Neurosciences Corporation Information
- 11.16.2 Minerva Neurosciences Description and Business Overview
- 11.16.3 Minerva Neurosciences Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Minerva Neurosciences Products Offered
- 11.16.5 Minerva Neurosciences Related Developments
- 11.17 Pernix Therapeutics
- 11.17.1 Pernix Therapeutics Corporation Information
- 11.17.2 Pernix Therapeutics Description and Business Overview
- 11.17.3 Pernix Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Pernix Therapeutics Products Offered
- 11.17.5 Pernix Therapeutics Related Developments
- 11.18 SkyePharma
- 11.18.1 SkyePharma Corporation Information
- 11.18.2 SkyePharma Description and Business Overview
- 11.18.3 SkyePharma Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 SkyePharma Products Offered
- 11.18.5 SkyePharma Related Developments
- 11.19 Paratek Pharmaceuticals
- 11.19.1 Paratek Pharmaceuticals Corporation Information
- 11.19.2 Paratek Pharmaceuticals Description and Business Overview
- 11.19.3 Paratek Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Paratek Pharmaceuticals Products Offered
- 11.19.5 Paratek Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Insomnia Medication Market Estimates and Projections by Region
- 12.1.1 Global Insomnia Medication Sales Forecast by Regions 2021-2026
- 12.1.2 Global Insomnia Medication Revenue Forecast by Regions 2021-2026
- 12.2 North America Insomnia Medication Market Size Forecast (2021-2026)
- 12.2.1 North America: Insomnia Medication Sales Forecast (2021-2026)
- 12.2.2 North America: Insomnia Medication Revenue Forecast (2021-2026)
- 12.2.3 North America: Insomnia Medication Market Size Forecast by Country (2021-2026)
- 12.3 Europe Insomnia Medication Market Size Forecast (2021-2026)
- 12.3.1 Europe: Insomnia Medication Sales Forecast (2021-2026)
- 12.3.2 Europe: Insomnia Medication Revenue Forecast (2021-2026)
- 12.3.3 Europe: Insomnia Medication Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Insomnia Medication Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Insomnia Medication Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Insomnia Medication Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Insomnia Medication Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Insomnia Medication Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Insomnia Medication Sales Forecast (2021-2026)
- 12.5.2 Latin America: Insomnia Medication Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Insomnia Medication Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Insomnia Medication Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Insomnia Medication Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Insomnia Medication Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Insomnia Medication Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Insomnia Medication Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Insomnia Medication Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Insomnia Medication. Industry analysis & Market Report on Insomnia Medication is a syndicated market report, published as Global Insomnia Medication Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Insomnia Medication market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
